Beilschmiedia acuta as a potential source of anticancer phytomedicine

Victor Kuete
DOI: https://doi.org/10.1016/bs.abr.2024.01.006
2024-02-07
Advances in Botanical Research
Abstract:Beilschmiedia acuta is a species of plant of the Lauraceae family and of the genus Beilschmiedia. The plant is used traditionally in the treatment of cancer and gastrointestinal infections. The plant has antibacterial and cytotoxic activities. In the present review, its cytotoxic potential was highlighted. It was found that the leaf and bark methanol extracts of the plant had cytotoxic toxic effects against several human cancer cell lines, including CCRF-CEM leukemia cells and its multidrug-resistant subline, CEM/ADR5000 cells, HCT116 p53 +/+ colon cancer cells and its resistant clones HCT116 p53 -/- , U87MG glioblastoma cells and its resistant U87MG.Δ EGFR subline, MDA-MB-231- pcDNA3 breast cancer cells, and its resistant subline, MDA-MB-231- BCRP as well as HepG2 hepatocarcinoma cells. It was also highlighted the leaf extract could be used to fight drug resistance of colon cancer. Further scientific investigations should be carried out on this plant to identify its bioactive constituents and to produce phytomedicines to combat several types of cancer.
plant sciences
What problem does this paper attempt to address?